John Fredericks Radio Atlanta, Articles S

In announcing the 41-year-old Londons elevation to Centenes top job, the company described her as at the forefront of innovation in healthcare . The salaries that employees earn in Centene can be influenced by the department or organization function that they work in. And less than a month ago, Centene said Neidorff was taking a medical leave of absence to address what he called a treatable medical condition, putting several executives including London to work to fill the void left by Neidorffs absence. Centene predicts big losses during Medicaid redeterminations Mari Devereaux Kris Tripplaar/Sipa USA Centene expects to lose an estimated 2.2 million Medicaid members during the redetermination. . As Centenes first woman CEO, London has been instrumental in helping the insurer boost earnings and grow its core lines of business. Drew Asher. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. March 22 (Reuters) - U.S health insurer Centene Corp CNC.N on Tuesday named Vice Chairman Sarah London as its new chief executive officer, effective immediately. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. Sarah London Work Experience and Education. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. We have a unique opportunity to empower our members, providers, and their communities in this transformation.. -Flexible schedules -Paid holidays including a floater to accommodate cultural differences -Compensation overall is okay -No meeting black out days to give focus days to get things done -CEO Sarah London is extremely smart, progressive, forward thinking leader -Potential of 14 week paid maternity leave -Earned time -Front loaded sick time. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, afterthe date hereof. In her management role, Ms. London led the Company's technology and digital strategy in addition to running the Health Care Enterprises and Specialty divisions, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Risk Management. Cision Distribution 888-776-0942 From September 2011 to June 2016, he served as the Company's Senior Vice President, Business Development. CENTENE IS COMMITTED TO CORPORATE SUSTAINABILITY . In a March 31 regulatory filing, Centene said its board of directors had approved a compensation package for new CEO Sarah London with an annual base salary of $1.4 million and a cash. Create an alert to follow a developing story, keep current on a competitor, or monitor industry news. "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members.". Neidorff, who is 79 years old and has been Centenes CEO since 1996, also took on a new role as executive chairman until the end of 2022, the company announced in December. The information shown here is a reporting of information included in the company's proxy statement. She started in data analytics at Optum and later was a partner in its venture capital arm. Sarah London leads Centene, a diversified enterprise that has grown to become the leading provider of government-sponsored healthcare, with an established expertise serving lower income and medically complex populations. Sarah London was named Centene CEO, taking over from Michael Neidorff, who will remain the company's chairman. CENTENE CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. In 2010, she helped start a health care cost and quality data business for Accretive Health, a medical billing and debt collection company. Centene Names Venture Capital Veteran CEO, Life Health > Health Insurance > Medicare Planning, News Published Mar 22, 2022 < 1 minute read. And for those of us who are survivors of US health plans, top payer Centene, after 25 years of one man at the top, now has a new CEO, effective immediately. Charlotte Ledger. Centene now provides or administers health coverage for about 26 million people. The health of individuals drives our focus on the environment, removing social barriers to health, and . "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. Managed care members jumped 1.1 million to 26.6 million. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; He continues to be the chairman. from 8 AM - 9 PM ET. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Neidorff remains on a previously announced medical leave of absence from his position on the board of the company. Between 2011 and 2020, Centene grew from 1.8M members in 12 states to 25.5M members nationwide. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. YEAR. Sarah London, vice chairman of the board of directors at Centene (NYSE: CNC), has accepted additional responsibilities as CEO of the St. Louis-based health insurer. Article content. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. Biography. Sarah London received her BA in Biology and Psychology from Middlebury College and her PhD in Neuroscience from UCLA. Based on our analysis, the employees in engineering earn salaries at Centene that are well above average, with yearly earnings averaging $97,613. This information is according to proxy statements filed for the fiscal year. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. Associate Professor . VP of Advanced Technology & Vice Chairman of Centene since . She replaces Michael Neidorff, who took a medical leave of absence in February 2022. . .advancing integrated, value-based care models through the development and application of data-driven insights and technology. Londons promotion to CEO is effective immediately, Centene said. March 22 (Reuters) - U.S. health insurer Centene Corp on Tuesday named Vice Chairman Sarah London as its new chief executive officer, replacing Michael Neidorff, who is on medical leave. 5.0 . Ms. London received an M.B.A. with High Honors from the University of Chicago Booth School of Business and a B.A. I have been consistently impressed by Sarahs passion to serve our members, who are often the most vulnerable amongst us.. Centene, which sells an array of government subsidized health insurance including Obamacare, has been working for much of this year on a permanent successor to Neidorff, who in December announced his plan to retire later this year.London takes over a company that is a national player among the biggest . By Tony Mecia. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. She soon moved to Humedica, a data analytics company. March 22 (Reuters) - U.S. health insurer Centene Corp CNC.N on Tuesday named Vice Chairman Sarah London as its new chief executive officer, replacing Michael Neidorff, who is on medical leave. ", "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. About Us; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS, (c) Election of Sarah London as Vice Chairman of the Board of Directors of Sarah London, Centene CEO, joins 'Power Lunch' to discuss disruptions in the Medicaid market, collaboration between Centene and state agencies and data driven decision-making to improve. Sarah London, previously appointed President, Health Care Enterprises and Executive Vice President of Advanced Technology, will continue in these roles. London started at Optum as the chief product officer at Optum Analytics. James Dallas, Centenes acting chairman, said the board sees London as a visionary leader. Centene Corporation, a Fortune 25 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. Twitter Revenue, Earnings Fell About 40% in December, WSJ Says, John Malone andCharter Directors Agree to $87.5 Million Settlement, China E-Commerce Giant JD Set for $1.4 Billion Discount Spree, Between Rounds of Golf, Trumps Searching for the Perfect DeSantis Diss, Your Saturday UK Briefing: Sunak Chalks Up a Win as the Budget Looms, Harrods Shrugs Off Recession Fears as Rich Get Richer, FT Says, Wealthy NYC Family Feuds Over $258 Million Madison Avenue Sale, Tom Sizemore, 'Saving Private Ryan' Actor, Dies at 61, The Exhibit Reality TV Show PittingArtist Against ArtistIs No Masterpiece. Prior to being appointed CEO in 2022, she served as Centenes Vice Chairman, responsible for strategy, technology, pharmacy services, enterprise compliance and quality, as well as for Centenes portfolio of independent, non-health plan companies. Big Jumps In Diversity Fuel Surge In U.S. Tennis Participation Since 2020, Walgreens-Backed VillageMD Buys 30-Location Physician Group In Connecticut, Banning Abortion Pill Mifepristone Would Set A Dangerous Precedent For The Politicization Of Public Health, Ukraine Wars Toll Of Death, Destruction, Displacement, And Trauma: Fresh Evidence Of Systematic Planning Of Torture Leaves Behind An Indelible Mark, Walmart To Double Health Clinic Footprint As Amazon And Rivals Buy Doctor Offices, Covid-19s Enormous Death Toll: Worldwide Life Expectancy Has Experienced A Steep Decline, Questions Scientists Should Now Explore With Respect To Covid-19, Sustainable Development A Smart Solution for Africa and the Middle East, And less than a month ago, Centene said Neidorff. Clayton-based Centene Corp. has appointed its vice board chair Sarah London as its new CEO. 1. Ms. Employees in the business development department receive relatively high salaries as well, where wages average $91,494 per year. There are 29 older and 1 younger executives at Centene. Sarah London, Chief Executive Officer, Centene Corporation Sarah London leads Centene, a diversified enterprise that has grown to become the leading provider of government-sponsored healthcare, with an established expertise serving lower income and medically complex populations. Chief Executive Officer. Opinions expressed by Forbes Contributors are their own. Search jobs. Share & Print. Effective with her election as Vice Chairman, Ms. London will have a base salary of $1,250,000 and a target annual cash bonus of 150% of her base salary. ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. A copy of the press release announcing the events described in Item 5.02 above To no one's great surprise, the pick is Sarah London, formerly vice chair of the Centene board of directors, one-third of their 'value creation office', and part of the Office of the . Since her appointment to lead the company in 2022, she has focused on developing a culture of transformation, implementing artificial intelligence and machine learning solutions to better improve health and quality of life for Centenes members. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Full-year profits declined to $1.35 billion, from $1.81 billion in 2020. Rapper, chef and author Action Bronson takes us on a journey from his early days at culinary school, to releasing critically acclaimed albums, to writing books, starring in TV shows and building an iconic brand around his favorite interests. Neidorff . Centene ( NYSE: CNC) said it had appointed Sarah London to succeed Michael Neidorff as the Chief . Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data. . Sarah London 67% approve of Sarah London's performance Founded 1984 Company size more than 10,000 Revenue more than $10B (USD) Industry Healthcare Insurance Headquarters 7700 Forsyth Blvd. Centene Corp. CNC (U.S.: NYSE) View All companies AT CLOSE 4:03 PM EST 01/05/23 $77.26 USD -2.20 -2.77% AFTER HOURS 6:24 PM EST 01/05/23 $76.26 -1.00 -1.29% AFTER HOURS Vol 211,456 Volume. ", "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. Centene has promoted Sarah London, the health insurance companys current board vice chair, to the job as Chief Executive Officer, succeeding the retiring Michael Neidorff, the company said Tuesday afternoon. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Executive Compensation Data Year: Trend Analysis As at CENTENE CORP, made $0 in total compensation. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. January 12, 2022, 8:01 AM Sarah London, Vice Chairman of Centene, joins Yahoo Finance Live to talk about Centene's health care initiatives, CMS changes, and how they are handling COVID-19. David Westin speaks with top names in finance about the week's biggest issues on Wall Street. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and . I have been consistently impressed by Sarah's passion to serve our members, who are often the most vulnerable amongst us. The most active insiders traders include Michael F Neidorff, Frederick H Eppinger, and Edward L Cahill. We have a unique opportunity to empower our members, providers, and their communities in this transformation. 831 salaries for 310 jobs at Centene in Santa Fe, TX. On average, Centene executives and independent directors trade stock every 17 days with the average trade being worth of $1,189,041. Net income dropped 26% to $1.3 billion. 2. Centene, which sells an array of government subsidized health insurance including Obamacare, has been working for much of this year on a permanent successor to Neidorff, who in December announced his plan to retire later this year. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. See reviews, salaries & interviews from Centene employees in MISSING VALUE. [40] Prior to being appointed Chief Executive Officer in 2022, she served as Centene's Vice Chairman, responsible for strategy, technology, pharmacy. All content is posted anonymously by employees working at Centene. Since Mr. Neidorff began a medical leave of absence in February 2022, she has been a member of the Office of the Chairman charged with running the day-to-day management of the Company. Biography. Biography. ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective. Spencer Stuart. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox. -, Health Net Providing Special Assistance to Members Affected by Winter Storms, Centene to present at barclays 2023 global healthcare conference, Mizuho Securities Adjusts Centene Price Target to $80 From $92, Maintains Neutral Rating. Fiscal Year Ended in 2016 Enter an executive or company name The charts on this page feature a breakdown of the total annual pay for the top executives at CENTENE CORPas reported in their proxy statements. Together, we can deliver innovative, integrated, and equitable care that meets our members where they live and exceeds their expectations. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.